- Home
- ILPT vs XOMA Comparison
ILPT vs XOMA Comparison
Compare ILPT & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ILPT | XOMA |
|---|---|---|
| Founded | 2017 | 1981 |
| Country | United States | United States |
| Employees | N/A | 14 |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 540.0M | 471.6M |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | ILPT | XOMA |
|---|---|---|
| Price | $8.66 | $41.97 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 4 |
| Target Price | $7.05 | ★ $52.50 |
| AVG Volume (30 Days) | ★ 491.3K | 97.9K |
| Earning Date | 04-29-2026 | 05-08-2026 |
| Dividend Yield | ★ 2.66% | N/A |
| EPS Growth | ★ 31.51 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $5.04 | $24.59 |
| Revenue Next Year | $2.18 | N/A |
| P/E Ratio | ★ N/A | $29.64 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.50 | $22.29 |
| 52 Week High | $9.17 | $42.81 |
Technical Indicators
Market Signals| Indicator | ILPT | XOMA |
|---|---|---|
| Relative Strength Index (RSI) | 54.52 | 59.20 |
| Support Level | $8.47 | $37.00 |
| Resistance Level | $9.16 | $42.25 |
| Average True Range (ATR) | 0.35 | 0.44 |
| MACD | -0.11 | -0.13 |
| Stochastic Oscillator | 53.85 | 69.64 |
Price Performance
Historical ComparisonAbout ILPT Industrial Logistics Properties Trust of Beneficial Interest
Industrial Logistics Properties Trust is a real estate investment trust. It owns and leases industrial and logistics properties throughout the United States. The company's investment portfolio includes industrial lands in Hawaii and industrial and logistics properties in other states. Rental revenue is earned from Hawaii Properties and Mainland Properties.
About XOMA XOMA Corporation
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates. The Company's drug royalty aggregator business is mainly focused on the acquisition of early to mid-stage clinical assets. Geographically, the company operates in Switzerland, the United States, Asia Pacific, Europe, and other regions.